200 related articles for article (PubMed ID: 11800507)
1. Continuous versus non-nightly use of zolpidem in chronic insomnia: results of a large-scale, double-blind, randomized, outpatient study.
Hajak G; Cluydts R; Declerck A; Estivill SE; Middleton A; Sonka K; Unden M
Int Clin Psychopharmacol; 2002 Jan; 17(1):9-17. PubMed ID: 11800507
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study.
Krystal AD; Erman M; Zammit GK; Soubrane C; Roth T;
Sleep; 2008 Jan; 31(1):79-90. PubMed ID: 18220081
[TBL] [Abstract][Full Text] [Related]
3. Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study.
Roehrs TA; Randall S; Harris E; Maan R; Roth T
Sleep; 2011 Feb; 34(2):207-12. PubMed ID: 21286241
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
5. Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study.
Roehrs TA; Randall S; Harris E; Maan R; Roth T
J Psychopharmacol; 2012 Aug; 26(8):1088-95. PubMed ID: 22004689
[TBL] [Abstract][Full Text] [Related]
6. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
[TBL] [Abstract][Full Text] [Related]
7. Comparison of continuous versus intermittent administration of zolpidem in chronic insomniacs: a double-blind, randomized pilot study.
Cluydts R; Peeters K; de Bouyalsky I; Lavoisy J
J Int Med Res; 1998; 26(1):13-24. PubMed ID: 9513073
[TBL] [Abstract][Full Text] [Related]
8. Eight weeks of non-nightly use of zolpidem for primary insomnia.
Walsh JK; Roth T; Randazzo A; Erman M; Jamieson A; Scharf M; Schweitzer PK; Ware JC
Sleep; 2000 Dec; 23(8):1087-96. PubMed ID: 11145323
[TBL] [Abstract][Full Text] [Related]
9. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
10. Zolpidem in the treatment of short-term insomnia: a randomized, double-blind, placebo-controlled clinical trial.
Dockhorn RJ; Dockhorn DW
Clin Neuropharmacol; 1996 Aug; 19(4):333-40. PubMed ID: 8828996
[TBL] [Abstract][Full Text] [Related]
11. Gender Differences in the Efficacy and Safety of Chronic Nightly Zolpidem.
Roehrs TA; Roth T
J Clin Sleep Med; 2016 Mar; 12(3):319-25. PubMed ID: 26446253
[TBL] [Abstract][Full Text] [Related]
12. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
13. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
14. A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia.
Tsutsui S;
J Int Med Res; 2001; 29(3):163-77. PubMed ID: 11471853
[TBL] [Abstract][Full Text] [Related]
15. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
[TBL] [Abstract][Full Text] [Related]
16. Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia.
Perlis ML; McCall WV; Krystal AD; Walsh JK
J Clin Psychiatry; 2004 Aug; 65(8):1128-37. PubMed ID: 15323600
[TBL] [Abstract][Full Text] [Related]
17. Zolpidem for persistent insomnia in SSRI-treated depressed patients.
Asnis GM; Chakraburtty A; DuBoff EA; Krystal A; Londborg PD; Rosenberg R; Roth-Schechter B; Scharf MB; Walsh JK
J Clin Psychiatry; 1999 Oct; 60(10):668-76. PubMed ID: 10549683
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a polyherbal sedative-hypnotic formulation NSF-3 in primary insomnia in comparison to zolpidem: a randomized controlled trial.
Maroo N; Hazra A; Das T
Indian J Pharmacol; 2013; 45(1):34-9. PubMed ID: 23543804
[TBL] [Abstract][Full Text] [Related]
19. "As needed" pharmacotherapy combined with stimulus control treatment in chronic insomnia--assessment of a novel intervention strategy in a primary care setting.
Hajak G; Bandelow B; Zulley J; Pittrow D
Ann Clin Psychiatry; 2002 Mar; 14(1):1-7. PubMed ID: 12046635
[TBL] [Abstract][Full Text] [Related]
20. Zolpidem and rebound insomnia--a double-blind, controlled polysomnographic study in chronic insomniac patients.
Monti JM; Attali P; Monti D; Zipfel A; de la Giclais B; Morselli PL
Pharmacopsychiatry; 1994 Jul; 27(4):166-75. PubMed ID: 7972349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
